Portfolio CFO

Samantha has extensive experience as a finance leader in life sciences sector. Most recently she was the CFO at CN-BIO an organ on a chip technology leader. Previously holding positions at Mestag Therapeutics, where she was a core part of the leadership team that secured the Company’s successful $45 million seed financing round and prior to that was at Horizon Discovery, supporting the strategic and M&A initiatives while preparing for a NASDAQ listing. Samantha was in the core team that supported the pre- and post-acquisition associated with the sale of the Group to PerkinElmer (now Revvity). Samantha has also held various leadership roles at the Johnson Matthey Pharma division, and at Cambridge Antibody Technology which led to leadership roles in Medimmune and AstraZeneca across multiple innovative medicine Therapeutic areas where she spent 10 years.

Prior to transitioning into life sciences, she qualified as a chartered accountant at PwC and held senior roles at PwC in UK and Australia. She has also successfully attained an MBA and PhD in international business and strategy from Loughborough University Business School.